+44 (0) 1223 755950
+1 832 327 7413
Human Hepatitis A Virus Cellular Receptor 1 (HAVCR1) Protein
REQUEST MORE INFO
Catalogue No: abx067643
Price:
US$217.50
(Size: 10 µg)
Reviews: 
(0 Publications and Reviews)
(0 Publications and Reviews)
Click on the image to see the image legend
Recombinant KIM-1 is a recombinant Human protein produced in a Prokaryotic expression system (E. coli).
Research Articles on Hepatitis A Virus Cellular Receptor 1 (HAVCR1)
| Target | Hepatitis A Virus Cellular Receptor 1 (HAVCR1) |
| Origin | Human |
| Expression | Recombinant |
| Tested Applications | WB, SDS-PAGE |
| Host | E. coli |
| Conjugation | Unconjugated |
| Form | Lyophilized |
| Purity | > 95% |
| Reconstitution | To keep the original salt concentration, we recommend reconstituting to the original concentration prior to lyophilization (see Concentration) in ddH2O. If a lower concentration is required, dilute in 20 mM Tris, 150 mM NaCl, pH 8.0. If a higher concentration is required, the product can be reconstituted directly in 20 mM Tris, 150 mM NaCl, pH 8.0, though please note that this will change the overall salt concentration. The stock concentration should be between 0.1-1.0 mg/ml. Do not vortex. |
| Storage | Store at 2-8 °C for up to one month. Store at -80 °C for up to one year. Avoid repeated freeze/thaw cycles. |
| UniProt Primary AC | Q96D42 (UniProt, ExPASy) |
| UniProt Secondary AC | O43656 |
| UniProt Entry Name | HAVR1_HUMAN |
| KEGG | hsa:26762 |
| String | 9606.ENSP00000344844 |
| Molecular Weight | Calculated MW: 55.1 kDa Observed MW: 55 kDa |
| Sequence Fragment | Ser21-Ala245 |
| Tag | N-terminal His tag and GST tag |
| Buffer | Prior to lyophilization: 20 mM Tris, 150 mM NaCl, pH 8.0, containing 1 mM EDTA, 1 mM DTT, 0.01% Sarcosyl, 5% Trehalose and Proclin-300. |
| Activity | Not tested |
| Concentration | Prior to lyophilization: 200 µg/ml |
| Availability | Shipped within 5-7 working days. |
| Note | This product is for research use only. Not for human consumption, cosmetic, therapeutic or diagnostic use. |